Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Evaluation of aerosol drug delivery with concurrent low- and high-flow nasal oxygen

Barry Murphy, Marc Mac Giolla Eain, Mary Joyce, James B. Fink, Ronan MacLoughlin
ERJ Open Research 2022 8: 00220-2022; DOI: 10.1183/23120541.00220-2022
Barry Murphy
1Research and Development, Science & Emerging Technologies, Aerogen Limited, Galway, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Barry Murphy
Marc Mac Giolla Eain
1Research and Development, Science & Emerging Technologies, Aerogen Limited, Galway, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marc Mac Giolla Eain
Mary Joyce
1Research and Development, Science & Emerging Technologies, Aerogen Limited, Galway, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mary Joyce
James B. Fink
2Aerogen Pharma Corporation, San Mateo, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James B. Fink
Ronan MacLoughlin
1Research and Development, Science & Emerging Technologies, Aerogen Limited, Galway, Ireland
3School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland
4School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ronan MacLoughlin
  • For correspondence: RMacLoughlin@aerogen.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 8 no. 4
DOI 
https://doi.org/10.1183/23120541.00220-2022

Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received May 9, 2022
  • Accepted July 15, 2022
  • Published online October 10, 2022.

Article Versions

  • previous version (July 22, 2022 - 04:49).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org

Author Information

  1. Barry Murphy1,
  2. Marc Mac Giolla Eain1,
  3. Mary Joyce1,
  4. James B. Fink2 and
  5. Ronan MacLoughlin1,3,4⇑
  1. 1Research and Development, Science & Emerging Technologies, Aerogen Limited, Galway, Ireland
  2. 2Aerogen Pharma Corporation, San Mateo, CA, USA
  3. 3School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland
  4. 4School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, Ireland
  1. Corresponding author: Ronan MacLoughlin (RMacLoughlin{at}aerogen.com)
View Full Text

Article usage

Article usage: July 2022 to December 2022

AbstractFullPdf
Jul 20225310451
Aug 2022339844
Sep 2022208233
Oct 202213393158
Nov 2022123092
Dec 2022519189

Altmetrics

PreviousNext
Back to top
Vol 8 Issue 4 Table of Contents
ERJ Open Research: 8 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of aerosol drug delivery with concurrent low- and high-flow nasal oxygen
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Evaluation of aerosol drug delivery with concurrent low- and high-flow nasal oxygen
Barry Murphy, Marc Mac Giolla Eain, Mary Joyce, James B. Fink, Ronan MacLoughlin
ERJ Open Research Oct 2022, 8 (4) 00220-2022; DOI: 10.1183/23120541.00220-2022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evaluation of aerosol drug delivery with concurrent low- and high-flow nasal oxygen
Barry Murphy, Marc Mac Giolla Eain, Mary Joyce, James B. Fink, Ronan MacLoughlin
ERJ Open Research Oct 2022, 8 (4) 00220-2022; DOI: 10.1183/23120541.00220-2022
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Materials and methods
    • Results
    • Discussion
    • Supplementary material
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Pulmonary pharmacology and therapeutics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Bacterial DNA amplifies neutrophilic inflammation in IL-17-exposed airways
  • PERSPIRE: a cohort study
  • Ipratropium bromide in EILO
Show more Original research articles

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society